Bixiye
QP40R1-19 Medical Drug Update for Drug Golodirsen (Vyondys 53)
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2019
Natiijooyinka Raadinta
Soo bandhiga 2691 - 2700 ee natiijooyinka 3697
Bixiye
QP40-19 Medical Drug Update for New to Market Golodirsen (Vyondys 53)
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2019
Bixiye
P1-20 New Medical, Medical Drug and Behavioral Health Policy Management Updates – Effective March 2, 2020
Taariikhda uu dhaqangalayo Barnaamijka: Jan 02, 2020
Bixiye
QP5-20 Pharmacy Benefit Exclusions
Taariikhda uu dhaqangalayo Barnaamijka: Jan 08, 2020
Bixiye
QP3-20 Addition of Mille Lacs Corporate Ventures to the American Indian Tribal Fee Schedule for Eligible Facility and Professional Services Provided to Purchased/Referred Care (PRC) – Eligible American Indians
Taariikhda uu dhaqangalayo Barnaamijka: Jan 08, 2020
Bixiye
QP2-20 MHCP Medical Dental Claim Denials
Taariikhda uu dhaqangalayo Barnaamijka: Jan 08, 2020
Bixiye
QP11-20 Pharmacy Benefit Exclusion for Budesonide-Formoterol Fumarate Dihydrate Aerosol
Taariikhda uu dhaqangalayo Barnaamijka: Jan 22, 2020
Bixiye
QP10-20 Pharmacy Benefit Exclusion for Xenleta TM, Asparlas TM, Ogivri TM and Tranexamic Acid/Sodium Chloride
Taariikhda uu dhaqangalayo Barnaamijka: Jan 22, 2020
Bixiye
QP9-20 Pharmacy Benefit Exclusion Healthcare Administered Drugs
Taariikhda uu dhaqangalayo Barnaamijka: Jan 22, 2020
Bixiye
QP15-20 Commercial Medical Drug Exclusion List Expanded to Include Avsola
Taariikhda uu dhaqangalayo Barnaamijka: Jan 22, 2020